It is a healthcare private limited company based in Kashipur, Uttarakhand, India, established in 2008.
2008 | Kashipur, Uttarakhand, India | ActiveCorona Pharmaceuticals Private Limited., a active private limited company, was established on 24 September 2008 in Kashipur, Uttarakhand, India. Engaging in preventive health services within the trade sector, it holds CIN: U85100UR2008PTC032700. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹7.67 M.
It upholds a compliant status. Employing 53 professional, Its leadership includes Satanshu Mathur (Director), Babita Dixit (Additional Director), Vivek Khandelwal (Director). Past directors included Suraj Arora, Pramod Kumar, Babita Dixit. It holds ₹2.14 Cr open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7Th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, 244713.
U85100UR2008PTC032700
032700
24 September 2008
₹1.30 Cr
₹7.67 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Corona Pharmaceuticals Private Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satanshu Mathur | Director | 10 Dec 2008 | Current |
| Babita Dixit | Additional Director | 01 Apr 2021 | Current |
| Vivek Khandelwal | Director | 31 Jul 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Dec 2008 | Past |
| Pramod Abcsdd | Director | 10 Dec 2008 | Past |
| Pramod Abcsdd | Director | 27 Aug 2018 | Past |
| Pramod Abcsdd | Additional Director | 09 Apr 2021 | Past |
| Pramod Abcsdd | Director | 27 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Corona Pharmaceuticals Private Limited., for the financial year ended 2024, experienced modest growth in revenue, with a 7.12% increase. The company also saw a substantial improvement in profitability, with a 142.36% increase in profit. The company's net worth Soared by an impressive increase of 148.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Corona Pharmaceuticals had a promoter holding of 24.20% and a public holding of 75.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,400,000.00
₹9,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2023 | Others | ₹1.40 M | Open |
| 30 Jun 2022 | Others | ₹2.00 Cr | Open |
| 06 Jul 2018 | Others | ₹9.50 M | Satisfied |
Explore comprehensive loan charge details -
Corona Pharmaceuticals has a workforce of 53 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Corona Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corona Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Corona Pharmaceuticals Private Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Corona Pharmaceuticals Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was recorded as a recent event.
A charge with Others amounted to Rs. 0.14 Cr with Charge ID 100770694 was registered on 14 Aug 2023. was recorded as a recent event.
Progress on Vivek Khandelwal was appointed as a Director was appointed as a Director on 31 Jul 2023 & has been associated with this company since 2 years 4 months . was documented.
A charge registered on 06 Jul 2018 via Charge ID 100190772 with Others was fully satisfied on 15 Jul 2022. was recorded as a recent event.
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100593888 was registered on 30 Jun 2022. was recorded as a recent event.
The CIN of Corona Pharmaceuticals Private Limited. is U85100UR2008PTC032700.
Corona Pharmaceuticals Private Limited. is headquartered at 7Th Milestone Jaspur Roas Kunda Crossing, Kashipur, Uttarakhand, 244713.
Corona Pharmaceuticals Private Limited. was incorporated on 24 September 2008.
The current directors of Corona Pharmaceuticals Private Limited. are
The primary industry of Corona Pharmaceuticals Private Limited. is Trade.
Corona Pharmaceuticals Private Limited. is unlisted.
The authorized capital of Corona Pharmaceuticals Private Limited. is ₹1.30 Cr, and the paid-up capital is ₹7.67 M.
The compliance status of Corona Pharmaceuticals Private Limited. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX